Company intelligence / Profile preview

Millenium Biologix

Kingston, Ontario, Canada

Ownership: Private
Employees: ~40
Development stage: Other

Overview

Millennium Biologix was a Canadian biotechnology company focused on the development and commercialization of advanced skeletal tissue regeneration products. The company's flagship technology, Skelite, is a patented synthetic bone graft substitute that closely mimics the mineral phase of natural bone and is designed to be resorbed by the body during the healing process. Its applications spanned orthopedic, spinal, and dental surgeries, providing a scaffold for new bone growth. In 2007, Millennium Biologix was acquired by Angiotech Pharmaceuticals to bolster their orthobiologics and biomaterials portfolio.

Therapeutic areas: RheumatologyOther
Modalities: DeviceBiomaterial
Industry: Surgical Medical Devices

Partnerships

Medtronic

Beyond the preview

Go deeper on Millenium Biologix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Millenium Biologix.

Explore the full profile